The Canada Nation

Your Trusted news Source

IMA

Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

1 day ago The Canada Nation

HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of...

Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary

Angel Yeast Releases 2025 Sustainability Report as Company Marks 40th Anniversary

4 hours ago The Canada Nation

The Gordie Howe bridge opening is being delayed over ‘outstanding issues’

The Gordie Howe bridge opening is being delayed over ‘outstanding issues’

4 hours ago The Canada Nation

Ottawa moves to crack down on forced labour products with new measures – National

Ottawa moves to crack down on forced labour products with new measures – National

4 hours ago The Canada Nation

Canada and France to deepen intelligence exchanges, Carney says in Paris – National

Canada and France to deepen intelligence exchanges, Carney says in Paris – National

4 hours ago The Canada Nation